BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• BioMidwest

  Biothera To Participate In Webcast On Advances In Cancer Immunotherapy

  June 18, 2015

   · 

  1 min read
• Business

  Yissum Ltd. And ICL Expand Research Collaboration In The Area Of Advanced Materials

  June 18, 2015

   · 

  1 min read
• Sosei Group Corporation Release: Planned Development Of Inhaled Triple Therapy QVM149 For Asthma

  June 18, 2015

   · 

  1 min read
• Business

  BMG Pharma S.r.l Announces The Signature Of A Distribution Agreement For Its Proprietary Product IALUXID Gel With Latam HQ Health Ltd. UK, For The Territory Of Central And South America; LatAm Hq Will Also Launch In The Same Territory Other Bmg Proprietar

  June 18, 2015

   · 

  3 min read
• Business

  ProNAi Therapeutics, Inc. Appoints Dr. Nicole Onetto And Mr. Robert Pelzer To Its Board Of Directors

  June 18, 2015

   · 

  2 min read
• Business

  Emulate Announces Strategic Collaboration With Johnson & Johnson Innovation To Use Organs-on-Chips Platform To Better Predict Human Response In Drug Development Process

  June 18, 2015

   · 

  6 min read
• BioMidwest

  W. L. Gore & Associates Global Registry For Endovascular Aortic Treatment Enrolls 3,000 Patients

  June 18, 2015

   · 

  4 min read
• Biotech Beach

  Biosense Webster, Inc. Launches CARTO 3 System CONFIDENSE Module For Optimized High-Density Mapping During Catheter Ablation Procedures

  June 18, 2015

   · 

  5 min read
• Business

  Anavex Strengthens Board Of Directors

  June 18, 2015

   · 

  2 min read
• Drug Development

  TG Therapeutics, Inc. Release: Updated Results From Phase II Clinical Trial Of TG-1101 (Ublituximab) In Combination With Ibrutinib Confirms Robust Clinical Activity With A Favorable Safety Profile In Patients With Previously Treated, High-Risk Chronic Lym

  June 18, 2015

   · 

  8 min read